Blood test tracks Parkinson progression

Trial ID
NCT05769699
Official Title
Serum Biomarkers in Parkinson's Disease at Different Stages
Goal
Blood test tracks Parkinson progression
Phase
NA
Status
RECRUITING
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Study Type
INTERVENTIONAL
Enrollment
200 participants
Conditions
Parkinson Disease
Interventions
blood sample

Plain-Language Summary

The goal is to find blood-based signals that change with Parkinson's stage, so a simple serum test might someday help diagnose or track disease progression. Participants give one or more blood samples so researchers can measure proteins, inflammatory markers, and other molecules in the serum that may reflect brain changes, the testing does not alter your Parkinson's treatment. Adults 18 to 80 with idiopathic Parkinson's disease by MDS criteria can join if they can consent, while pregnant people and those with inflammatory or autoimmune diseases are excluded.

Locations

  • Flavia Torlizzi, Roma, Italy

Frequently Asked Questions

What is this trial testing?
This trial is studying blood sample. The goal is to find blood-based signals that change with Parkinson's stage, so a simple serum test might someday help diagnose or track disease progression. Participants give one or more blood samples so researchers can measure proteins, inflammatory markers, and other molecules in the serum that may reflect brain changes, the testing does not alter your Parkinson's treatment. Adults 18 to 80 with idiopathic Parkinson's disease by MDS criteria can join if they can consent, while pregnant people and those with inflammatory or autoimmune diseases are excluded.
Who can participate?
Participants must be between 18 Years and 80 Years.
Where is this trial located?
This trial is recruiting at 1 location.
Does it cost anything to join?
No. There is no cost to participate. Study-related care and treatment are provided at no charge.
How long does the trial last?
This trial is estimated to last approximately 1 year and 11 months.

View on ClinicalTrials.gov